Free delivery over $100 Learn more

30 days return period Learn more
SKU: 359BIC

Human Heme-Oncology Peripheral Blood Mononuclear Cells

Blood and Immune Cells & Products > Peripheral Blood Mononuclear Cells (PBMCs)

Product Type: Diseased Human Peripheral Blood Mononuclear Cells

Species: Human

Cell Type: Immune Cells

Source Organ: Blood

$1,249.00
Size

Care information

Display general product information or specific product information using metafields.

Delivery and Shipping

Add some general information about your delivery and shipping policies.

Cell Name: Human Heme-Oncology Peripheral Blood Mononuclear Cells

  • Description
    Human Heme-Oncology Peripheral Blood Mononuclear Cells are a type of mononuclear cell population derived from peripheral blood, mainly including lymphocytes (T cells, B cells, NK cells) and monocytes. Peripheral blood from patients with hematologic oncology conditions (e.g., leukemia, lymphoma, myeloma) .Round mononuclear cells; suspension growth; weak/no adhesion
    .PBMCs play an important role in immune regulation: T/B cells mediate adaptive immunity (antigen recognition, antibody production), NK cells perform natural killing functions, and monocytes can differentiate into macrophages or dendritic cells, participating in antigen presentation and inflammation regulation. PBMCs themselves are non-tumorigenic, but may include malignant cells in the hematologic cancer context. PBMCs reflect immune dysregulation in hematologic cancers, influencing tumor immune escape, inflammation, and immune surveillance.
  • Product Name
    Human Heme-Oncology Peripheral Blood Mononuclear Cells
  • Product Type
    Diseased Human Peripheral Blood Mononuclear Cells
  • Species
    Human
  • Cell Type
    Mononuclear Cell
  • Source Organ
    Peripheral Blood
  • Disease
    Heme-Oncology
  • Product Type
    Diseased Human Peripheral Blood Mononuclear Cells
  • Growth Conditions
    37 °C, 5% CO2
  • Application
    Human Heme-Oncology Peripheral Blood Mononuclear Cells can be used to study the pathogenesis of hematological malignancies such as lymphoma and leukemia, evaluate drug efficacy, and develop new treatment strategies. For example, when evaluating new antibody drugs for hematological tumors, they can be used as effector cells to detect the antibody-dependent cellular cytotoxicity (ADCC) activity of antibodies
  • Size/Quantity
    1 vial
  • Quality Control
    All cells test negative for mycoplasma, bacteria, yeast, and fungi.
  • Shipping Conditions
    Dry Ice
  • Storage
    Liquid Nitrogen

Payment & Security

Payment methods

    Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

    • Visit our support center

      Expert help & advice

    • Check your order status

      Updates & tracking

    • Returns & exchanges

      All you need to know

    • Price-match guarantee

      Our promise to you